Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 29,743Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 19Bayer AG

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Larotrectinib

Brand Name : Vitrakvi capsules

Dosage Form : Capsule

Dosage Strength : 25mg

Packaging :

Approval Date : 28/05/2020

Application Number : 67281

Regulatory Info : Allowed

Registration Country : Switzerland

blank

02

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Larotrectinib

Brand Name : Vitrakvi capsules

Dosage Form : Capsule

Dosage Strength : 100mg

Packaging :

Approval Date : 28/05/2020

Application Number : 67281

Regulatory Info : Allowed

Registration Country : Switzerland

blank

03

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Larotrectinib

Brand Name : Vitrakvi oral solution

Dosage Form : Oral Solution

Dosage Strength : 20mg/ml

Packaging :

Approval Date : 28/05/2020

Application Number : 67282

Regulatory Info : Allowed

Registration Country : Switzerland

blank

04

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Larotrektinibsulfat

Brand Name : Vitrakvi

Dosage Form : Capsule

Dosage Strength : 100mg

Packaging :

Approval Date : 19/09/2019

Application Number : 20180827000040

Regulatory Info : Approved

Registration Country : Sweden

blank

05

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Larotrektinibsulfat

Brand Name : Vitrakvi

Dosage Form : Oral Solution

Dosage Strength : 1000mg/50ml

Packaging :

Approval Date : 18/08/2021

Application Number : 20210527000054

Regulatory Info : Approved

Registration Country : Sweden

blank

06

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Larotrektinibsulfat

Brand Name : Vitrakvi

Dosage Form : Oral Solution

Dosage Strength : 2000mg/100ml

Packaging :

Approval Date : 19/09/2019

Application Number : 20180827000057

Regulatory Info : Approved

Registration Country : Sweden

blank

07

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Larotrektinibsulfat

Brand Name : Vitrakvi

Dosage Form : Capsule

Dosage Strength : 25mg

Packaging :

Approval Date : 19/09/2019

Application Number : 20180827000033

Regulatory Info : Approved

Registration Country : Sweden

blank

08

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Larotrectinib

Brand Name : Vitrakvi

Dosage Form :

Dosage Strength :

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

09

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Larotrectinib

Brand Name : Vitrakvi

Dosage Form :

Dosage Strength :

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

10

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Larotrectinib

Brand Name : Vitrakvi

Dosage Form :

Dosage Strength :

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

11

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Larotrectinib

Brand Name : Vitrakvi

Dosage Form :

Dosage Strength :

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

12

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Larotrectinib

Brand Name : Vitrakvi

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

13

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Larotrectinib

Brand Name : Vitrakvi

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

14

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Larotrectinib

Brand Name : Vitrakvi

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

15

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Larotrectinib

Brand Name : Vitrakvi

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

16

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Larotrectinib

Brand Name : Vitrakvi

Dosage Form :

Dosage Strength :

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

17

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Larotrectinib

Brand Name : Vitrakvi

Dosage Form :

Dosage Strength :

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

18

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Larotrectinib

Brand Name : Vitrakvi

Dosage Form :

Dosage Strength :

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

19

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Larotrectinib

Brand Name : Vitrakvi

Dosage Form :

Dosage Strength :

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank